Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis.
作者信息
Toledo Paula Virginia Michelon, Tuon Felipe Francisco, Arend Lavinia, Aranha Junior Ayrton Alves
机构信息
Medicine Department, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brazil; Internal Medicine Postgraduate Programme, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Medicine Department, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brazil; Division of Infectious Diseases, Universidade Federal do Paraná, Curitiba, PR, Brazil; Internal Medicine Postgraduate Programme, Universidade Federal do Paraná, Curitiba, PR, Brazil.
出版信息
Braz J Infect Dis. 2014 Sep-Oct;18(5):574-5. doi: 10.1016/j.bjid.2014.05.003. Epub 2014 Jun 5.
Abstract
摘要
相似文献
1
Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis.替加环素、多黏菌素、庆大霉素、美罗培南及其联合用药在实验性产肺炎克雷伯菌碳青霉烯酶肺炎克雷伯菌非致死性败血症中的疗效。
Braz J Infect Dis. 2014 Sep-Oct;18(5):574-5. doi: 10.1016/j.bjid.2014.05.003. Epub 2014 Jun 5.
2
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?美罗培南治疗产KPC肺炎克雷伯菌血流感染：我们是否应探究这一矛盾现象的药代动力学/药效学根源？
Virulence. 2017 Jan 2;8(1):66-73. doi: 10.1080/21505594.2016.1213476. Epub 2016 Jul 18.
3
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.碳青霉烯类抗生素节约方案治疗重症监护病房产碳青霉烯酶肺炎克雷伯菌感染
Clin Infect Dis. 2013 Mar;56(5):697-700. doi: 10.1093/cid/cis969. Epub 2012 Nov 15.
4
Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient.一名患者肺炎克雷伯菌对替加环素耐药性的演变
Ann Saudi Med. 2010 Sep-Oct;30(5):404-7. doi: 10.4103/0256-4947.67087.
5
In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.多药耐药肺炎克雷伯菌和大肠埃希菌体内出现替加环素耐药。
Antimicrob Agents Chemother. 2012 Aug;56(8):4516-8. doi: 10.1128/AAC.00234-12. Epub 2012 May 29.
6
Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.利用蒙特卡罗模拟评估替加环素和米诺环素治疗产碳青霉烯酶肺炎克雷伯菌肺炎的疗效。
Infect Dis (Lond). 2018 Jul;50(7):507-513. doi: 10.1080/23744235.2018.1423703. Epub 2018 Jan 9.
7
Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.替加环素联合黏菌素、美罗培南、利福平或庆大霉素对产KPC肠杆菌科细菌在小鼠大腿感染模型中的活性。
Antimicrob Agents Chemother. 2013 Dec;57(12):6028-33. doi: 10.1128/AAC.00891-13. Epub 2013 Sep 23.
8
Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.替加环素治疗重症患者产碳青霉烯酶肺炎克雷伯菌感染
Scand J Infect Dis. 2014 Mar;46(3):175-80. doi: 10.3109/00365548.2013.861608. Epub 2013 Dec 20.
9
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.体外评估不同抗菌药物组合对产碳青霉烯酶肺炎克雷伯菌的抗菌活性：双碳青霉烯方案的活性与美罗培南 MIC 值相关。
J Antimicrob Chemother. 2017 Jul 1;72(7):1981-1984. doi: 10.1093/jac/dkx084.
10
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase.替加环素单独及联合治疗产 KPC 碳青霉烯酶肺炎克雷伯菌体外药效动力学研究
Antimicrob Agents Chemother. 2011 Apr;55(4):1420-7. doi: 10.1128/AAC.01253-10. Epub 2011 Jan 31.
引用本文的文献
1
Synergistic Activity of Vancomycin and Gentamicin Against Biofilms on Polyurethane Surface.万古霉素与庆大霉素对聚氨酯表面生物膜的协同活性
Microorganisms. 2025 May 13;13(5):1119. doi: 10.3390/microorganisms13051119.
2
Antagonistic effect between tigecycline and meropenem: from bed to bench to bed.替加环素与美罗培南之间的拮抗作用：从临床到实验室再到临床
Infection. 2020 Feb;48(1):141-142. doi: 10.1007/s15010-019-01353-y. Epub 2019 Sep 6.
3
Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection.替加环素与美罗培南拮抗作用：成功治疗产 KPC 肺炎克雷伯菌感染。
Infection. 2019 Jun;47(3):497-500. doi: 10.1007/s15010-019-01274-w. Epub 2019 Feb 7.
4
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.产超广谱β-内酰胺酶、AmpC 酶和碳青霉烯酶肠杆菌科细菌感染的治疗。
Clin Microbiol Rev. 2018 Feb 14;31(2). doi: 10.1128/CMR.00079-17. Print 2018 Apr.
5
Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae.耐碳青霉烯类肠杆菌科细菌所致呼吸机相关性肺炎患者的死亡危险因素
Braz J Infect Dis. 2017 Jan-Feb;21(1):1-6. doi: 10.1016/j.bjid.2016.09.008. Epub 2016 Nov 4.
6
Activity of antimicrobial combinations against KPC-2-producing Klebsiella pneumoniae in a rat model and time-kill assay.抗菌药物联合对大鼠模型中产KPC-2肺炎克雷伯菌的活性及时间杀菌试验
Antimicrob Agents Chemother. 2015 Jul;59(7):4301-4. doi: 10.1128/AAC.00323-15. Epub 2015 Apr 20.
本文引用的文献
1
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.治疗产碳青霉烯酶肺炎克雷伯菌（KPC）感染：已发表的病例系列和病例报告综述。
Ann Clin Microbiol Antimicrob. 2012 Dec 13;11:32. doi: 10.1186/1476-0711-11-32.
2
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.替加环素单独及联合黏菌素和美罗培南对产碳青霉烯酶肠杆菌科细菌（KPC）菌株的时间杀菌试验研究。
Int J Antimicrob Agents. 2011 Mar;37(3):244-7. doi: 10.1016/j.ijantimicag.2010.10.031. Epub 2011 Jan 13.
Zotero 插件